Structure-function studies of DT-diaphorase (NQO1) and NRH:quinone oxidoreductase (NQO2)

Free Radical Biology and Medicine

Volumn 29, Issue 3-4, 2000, Pages 276-284

  Chen, Shiuan ^a   Wu, Kebin ^a   Knox, Richard ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Enzacta Ltd   (United Kingdom)

Author keywords

CB1954; DT diaphorase; Free radicals; NQO1; NQO2; Prodrug; Site directed mutagenesis

Indexed keywords

OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

AMINO ACID SEQUENCE; ELECTRON TRANSPORT; ENZYME ACTIVITY; ENZYME STRUCTURE; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

STAPHYLOCOCCUS PHAGE 187;

EID: 0033805383     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00308-7     Document Type: Article

References (53)

1. Ernster L., Navazioi F. Soluble diaphorase in animal tissues. Acta Chem. Scand. 12:1958;595.
2. Ernster L., Liunggren M., Danielson L. Purification and some properties of a highly dicumarol-sensitive liver diaphorase. Biochem. Biophys. Res. Commun. 2:1960;88-92.
3. Jaiswal A.K., Burnett P., Adesnik M., McBride O.W. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6. Biochemistry. 29:1990;1899-1906.
4. Wu K., Knox R., Sun X.Z., Joseph P., Jaiswal A.K., Zhang D., Deng P.S.-K., Chen S. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase. Arch. Biochem. Biophys. 347:1997;221-228.
5. Liao S., Dulaney J.T., Williams-Ashman H.G. Purification and properties of a flavoprotein catalyzing the oxidation of reduced ribosyl nicotinamide. J. Biol. Chem. 237:1962;2981-2987.
6. Chen S., Knox R., Lewis A.D., Friedlos F., Workman P., Deng P.S.K., Fung M., Ebenstein D., Wu K., Tsai T.-M. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase study involving mouse, rat, human, and mouse-rat chimeric enzymes . Mol. Pharmacol. 47:1995;934-939.
7. Chen S., Knox R., Wu K., Deng P.S.-K., Zhou D., Bianchet M.A., Amzel L.M. Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse. J. Biol. Chem. 272:1997;1437-1439.
8. Chen S., Wu K., Zhang D., Sherman M., Knox R., Yang C.S. Molecular characterization of binding of substrates and inhibitors to DT-diaphorase combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling . Mol. Pharmacol. 56:1999;272-278.
9. Ernster L. DT diaphorase a historical review . Chemica Scripta. 27A:1987;1-13.
10. Robertson J.A., Chen H.-C., Nebert D.W. NAD(P)H:menadione oxidoreductase novel purification of enzyme, cDNA, and complete amino acid sequence, and gene regulation . J. Biol. Chem. 261:1986;15794-15799.
11. Bayney R.M., Rodkey J.A., Bennett C.D., Lu A.R.H., Pickett C.B. Rat liver NAD(P)H:quinone reductase nucleotide sequence analysis of a quinone reductase cDNA clone and prediction of the amino acid sequence of the corresponding protein. J. Biol. Chem. 262:1987;572-575.
12. Haniu M., Yuan H., Chen S., Iyanagi T., Lee T.D., Shively J.E. Structure-function relationship of NAD(P)H:quinone reductase characterization of NH2-terminal blocking group and essential tyrosine and lysine residues . Biochemistry. 27:1988;6877-6883.
13. Jaiswal A.K., McBride O.W., Adesnik M., Nebert D.W. Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase cDNA sequence and localization of gene to chromosome 16 . J. Biol. Chem. 263:1988;13572-13578.
14. Chen S., Clarke P.E., Martino P.A., Deng P.S.K., Yeh C.-H., Lee T.D., Prochaska H.J., Talalay P. Mouse liver NAD(P)H:quinone acceptor oxidoreductase protein sequence analysis by tandem mass spectrometry, cDNA cloning, expression in Escherichia coli, and enzyme activity analysis . Protein Sci. 3:1994;1296-1304.
15. Chen H.H., Ma J.X., Forrest G.L., Deng P.S.K., Martino P., Lee T.D., Chen S. Expression of rat liver NAD(P)H:quinone acceptor oxidoreductase in E. coli and in vitro mutagenesis at Arg-177. Biochem. J. 284:1992;855-860.
16. Liu X.-F., Yuan H., Haniu M., Iyanagi T., Shively J.E., Chen S. Reaction of rat liver DT-diaphorase (NAD(P)H:quinone acceptor reductase) with 5′-[p-(fluorosulfonyl)benzoyl]-adenosine. Mol. Pharmacol. 35:1989;818-822.
17. +. Biochemistry. 30:1991;6942-6948.
18. Forrest G.L., Qian J., Ma J.-X., Kaplan W.D., Akman S., Doroshow J., Chen S. Rat liver NAD(P)H:quinone oxidoreductase cDNA expression and site-directed mutagenesis . Biochem. Biophys. Res. Commun. 169:1990;1087-1093.
19. Ma Q., Cui K., Wang R.W., Lu A.Y.H., Yang C.S. Site-directed mutagenesis of rat liver NAD(P)H:quinone oxidoreductase roles of lysine 76 and cysteine 179 . Arch. Biochem. Biophys. 294:1992;434-439.
20. Ma Q., Cui K., Xiao F., Lu A.Y.H., Yang C.S. Identification of a glycine-rich sequence as an NAD(P)H-binding site and tyrosine 128 as a dicoumarol-binding site in rat liver NAD(P)H:quinone oxidoreductase by site-directed mutagenesis. J. Biol. Chem. 267:1992;22298-22304.
21. Cui K., Ma Q., Lu A.Y.H., Yang C.S. Roles of histidine-194, aspartate-163, and a glycine-rich sequence of NAD(P)H:quinone oxidoreductase in the interaction with nicotinamide coenzymes. Arch. Biochem. Biophys. 323:1995;265-273.
22. Li R., Bianchet M.A., Talalay P., Amzel L.M. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy mechanism of the two-electron reaction . Proc. Natl. Acad. Sci. USA. 92:1995;8846-8850.
23. Faig M., Bianchet M.A., Talalay P., Chen S., Winski S., Ross D., Amzel L.M. Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases species comparison and structural changes with substrate binding and release . Proc. Natl. Acad. Sci. USA. 97:2000;3177-3182.
24. Wallin R., Gerhardt O., Prydz H. NAD(P)H dehydrogenase and its role in the vitamin K (2-methyl-3-phytyl-1,4-naphthaquinone)-dependent carboxylation reaction. Biochem. J. 169:1978;95-101.
25. Lind C., Hochstein P., Ernster L. DT-diaphorase properties, reaction mechanism, metabolic function. A progress report. King T.E., Mason H.S., Morrison M. Symposium on oxidases and related redox systems. 1979;321-347 Pergamon Press, New York.
26. Hollander P.M., Ernster L. Studies on the reaction mechanism of DT-diaphorase. Action of dead-end inhibitors and effects of phospholipids. Arch. Biochem. Biophys. 169:1975;560-567.
27. Liu X.-F., Liu M.-L., Iyanagi T., Legesse K., Lee T.D., Chen S. Inhibition of rat liver DT-diaphorase (NAD(P)H:quinone acceptor reductase) by flavonoids isolated from the Chinese herb, Scutellariae Radix (Huang Qin). Mol. Pharmacol. 37:1990;911-915.
28. Siegel D., Gibson N.W., Preusch P.C., Ross D. Metabolism of diaziquone by NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase) role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells . Cancer Res. 50:1990;7293-7300.
29. Siegel D., Gibson N.W., Preusch P.C., Ross D. Metabolism of mitomycin C by DT-diaphorase role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells . Cancer Res. 50:1990;7483-7489.
30. Walton M.I., Smith P.J., Workman P. The role of NAD(P)H:quinone reductase (EC 1. 6. 99. 2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9. Cancer Commun. 3:1991;199-206.
31. Boland M.P., Knox R.J., Roberts J.J. The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide). Biochem. Pharmacol. 41:1991;867-875.
32. Lin A.J., Cosby L.A., Shansky C.W., Sartorelli A.C. Potential bioreductive alkylating agents. 1. Benzoquinone derivatives. J. Med. Chem. 15:1972;1247-1252.
33. Traver R.D., Horikoshi T., Danenberg K.D., Stadlbauer T.H., Danenberg P.V., Ross D., Gibson N.W. NAD(P):quinone oxidoreductase gene expression in human colon carcinoma cells characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity . Cancer Res. 52:1992;797-802.
34. Pan S.S., Forrest G.L., Akman S.A., Hu L.T. NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells. . Cancer Res. 55:1995;330-335.
35. Bachur N.R., Gordon S.L., Gee M.V., Kon H. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P450 reductase and xanthine oxidase. J. Biol. Chem. 259:1979;959-966.
36. Pan S.S., Andrews P.A., Glover C.J. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P450 reductase and xanthine oxidase. J. Biol. Chem. 259:1984;959-966.
37. Marshall R.S., Paterson M.C., Rauth A.M. Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual. Biochem. Pharmacol. 41:1991;1351-1360.
38. Dulhanty A.M., Whitmore G.F. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase. . Cancer Res. 51:1991;1860-1865.
39. Knox R.J., Friedlos F., Boland M.P. The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT). Cancer Metastasis Rev. 12:1993;195-212.
40. Knox R.J., Boland M.P., Friedlos F., Coles B., Southan C., Roberts J.J. The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1. 6. 99. 2). Biochem. Pharmacol. 37:1988;4671-4677.
41. Knox R.J., Friedlos F., Jarman M., Robert J.J. A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells. Biochem. Pharmacol. 37:1988;4661-4669.
42. Knox R.J., Friedlos F., Marchbank T., Robert J.J. Bioactivation of CB 1954 reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA-DNA interstrand cross-linking species . Biochem. Pharmacol. 42:1991;1691-1697.
43. Benson A.M., Hunkeler M.J., Talalay P. Increase of NAD(P)H:quinone reductase by dietary antioxidants possible role in protection against carcinogenesis and toxicity . Proc. Natl. Acad. Sci. USA. 77:1980;5216-5220.
44. Iyanagi T., Yamazaki I. One-electron-transfer reactions in biochemical systems. V. Difference in the mechanism of quinone reductase by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase). Biochim. Biophys. Acta. 216:1970;282-294.
45. Iyanagi T. On the mechanisms of one- and two-electron transfer by flavin enzymes. Chemica Scripta. 27A:1987;31-36.
46. Tedeschi G., Chen S., Massey V. DT-diaphorase. Redox Potential, steady-state, and rapid reaction studies. J. Biol. Chem. 270:1995;1198-1204.
47. Tedeschi G., Chen S., Massey V. Active site studies of DT-diaphorase employing artifical flavins. J. Biol. Chem. 270:1995;2512-2516.
48. Kuehl B.L., Paterson J.W.E., Peacock J.W., Paterson M.C., Rauth A.M. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br. J. Cancer. 72:1995;555-561.
49. Schulz W.A., Krummeck A., Rosinger I., Eickelmann P., Neuhaus C., Ebert T., Schmitz-Drager B.J., Sies H. Increased frequency of a null-allele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics. 7:1977;235-239.
50. Wu K., Deng P.S.-K., Chen S. Catalytic properties of a naturally occurring mutant of human NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase), Pro-187 to Ser. Yagi K. Pathophysiology of lipid peroxides and related free radicals. 1998;135-148 Karger, Basel, Switzerland.
51. Tedeschi G., Deng P.S.-K., Chen H.H., Massey V., Forrest G.L., Chen S. Involvement of Lys-113 in the binding of the FAD prosthetic group of NAD(P)H:quinone acceptor oxidoreductase. Arch. Biochem. Biophys. 321:1995;76-82.
52. Gasdaska P.Y., Fisher H., Powis G. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lackingthe putative quinone substrate binding site is present in human normal and tumor tissues. Cancer Res. 55:1995;2542-2547.
53. Chen S., Deng P.S.-K., Bailey J., Swiderek K.M. A two-domain structure for the two subunits of NAD(P)H:quinone acceptor oxidoreductase. Protein Sci. 3:1994;51-57.